84 related articles for article (PubMed ID: 20125118)
21. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
[TBL] [Abstract][Full Text] [Related]
23. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
[TBL] [Abstract][Full Text] [Related]
25. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
[TBL] [Abstract][Full Text] [Related]
26. Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells.
Lee KD; Pai MY; Hsu CC; Chen CC; Chen YL; Chu PY; Lee CH; Chen LT; Chang JY; Huang TH; Hsiao SH; Leu YW
Biochem Biophys Res Commun; 2012 Jun; 422(4):578-85. PubMed ID: 22595458
[TBL] [Abstract][Full Text] [Related]
27. Aberrant CpG islands' hypermethylation of ABCB1 in mesenchymal stem cells of patients with steroid-associated osteonecrosis.
Sun Z; Yang S; Ye S; Zhang Y; Xu W; Zhang B; Liu X; Mo F; Hua W
J Rheumatol; 2013 Nov; 40(11):1913-20. PubMed ID: 24037553
[TBL] [Abstract][Full Text] [Related]
28. Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance.
Miklos W; Pelivan K; Kowol CR; Pirker C; Dornetshuber-Fleiss R; Spitzwieser M; Englinger B; van Schoonhoven S; Cichna-Markl M; Koellensperger G; Keppler BK; Berger W; Heffeter P
Cancer Lett; 2015 May; 361(1):112-20. PubMed ID: 25749419
[TBL] [Abstract][Full Text] [Related]
29. Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer.
Raguz S; Randle RA; Sharpe ER; Foekens JA; Sieuwerts AM; Meijer-van Gelder ME; Melo JV; Higgins CF; Yagüe E
Int J Cancer; 2008 Mar; 122(5):1058-67. PubMed ID: 17955490
[TBL] [Abstract][Full Text] [Related]
30. Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells.
Fyrberg A; Peterson C; Kågedal B; Lotfi K
Cancer Chemother Pharmacol; 2011 Sep; 68(3):583-91. PubMed ID: 21110023
[TBL] [Abstract][Full Text] [Related]
31. Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma.
Vaclavikova R; Klajic J; Brynychova V; Elsnerova K; Alnaes GIG; Tost J; Kristensen VN; Rob L; Kodet R; Skapa P; Mrhalova M; Soucek P
Oncol Rep; 2019 Aug; 42(2):763-774. PubMed ID: 31173253
[TBL] [Abstract][Full Text] [Related]
32. A potential role of fetal hemoglobin in the development of multidrug resistance.
Fyrberg A; Skoglund K; Wolk M; Lotfi K
Biochem Biophys Res Commun; 2012 Oct; 427(3):456-60. PubMed ID: 22910410
[TBL] [Abstract][Full Text] [Related]
33. Reduced BMP6 expression by DNA methylation contributes to EMT and drug resistance in breast cancer cells.
Liu G; Liu YJ; Lian WJ; Zhao ZW; Yi T; Zhou HY
Oncol Rep; 2014 Aug; 32(2):581-8. PubMed ID: 24890613
[TBL] [Abstract][Full Text] [Related]
34. Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
Kubiliute R; Januskeviciene I; Urbanaviciute R; Daniunaite K; Drobniene M; Ostapenko V; Daugelavicius R; Jarmalaite S
Sci Rep; 2021 Mar; 11(1):6556. PubMed ID: 33753859
[TBL] [Abstract][Full Text] [Related]
35. Methylation of WTH3, a possible drug resistant gene, inhibits p53 regulated expression.
Tian K; Wang Y; Huang Y; Sun B; Li Y; Xu H
BMC Cancer; 2008 Nov; 8():327. PubMed ID: 18992151
[TBL] [Abstract][Full Text] [Related]
36. The effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatment.
Reed K; Parissenti AM
Pharmacogenomics; 2011 Oct; 12(10):1465-83. PubMed ID: 22008050
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line.
Chen KG; Wang YC; Schaner ME; Francisco B; Durán GE; Juric D; Huff LM; Padilla-Nash H; Ried T; Fojo T; Sikic BI
Cancer Res; 2005 Oct; 65(20):9388-97. PubMed ID: 16230402
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of DNA methylation profiles of the CpG island of the ABCB1 gene in dogs with lymphoma.
Tomiyasu H; Fujiwara-Igarashi A; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Am J Vet Res; 2014 Sep; 75(9):835-41. PubMed ID: 25157887
[TBL] [Abstract][Full Text] [Related]
39. Perturbations in 3D genome organization can promote acquired drug resistance.
Manjón AG; Manzo SG; Prekovic S; Potgeter L; van Schaik T; Liu NQ; Flach K; Peric-Hupkes D; Joosten S; Teunissen H; Friskes A; Ilic M; Hintzen D; Franceschini-Santos VH; Zwart W; de Wit E; van Steensel B; Medema RH
Cell Rep; 2023 Oct; 42(10):113124. PubMed ID: 37733591
[TBL] [Abstract][Full Text] [Related]
40. [Aberrant DNA methylation and drug resistance of tumor cells].
Xinxin S; Yujie S
Yi Chuan; 2014 May; 36(5):411-9. PubMed ID: 24846990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
